Back to results
US 2023/0055086 A1Published application
Inter-alpha inhibitor proteins
AssigneeProThera Biologics, Inc.
InventorsYow-Pin Lim, Denice Spero
Life of this patent
Estimating the term…
Abstract
Described herein are methods for quantifying IAIP levels in a sample.
Claims1
A method for quantifying Inter-alpha-Inhibitor (IαI) and Pre-alpha-Inhibitor (PαI) in a sample from a subject comprising:
- a) contacting the sample with a binding agent to produce an IαI or PαI binding agent complex, wherein the binding agent is bound to a support;
- b) contacting the IαI or PαI binding agent complex with a detection agent;
- and
- c) detecting an amount of the detection agent bound to the IαI or PαI binding agent complex
- wherein the IαI or PαI comprises at least one heavy chain selected from the group consisting of H1, H2, and H3 chain;
- wherein the binding agent comprises an antibody, and the detection agent comprises a ligand that binds to at least one heavy chain,
- thereby quantifying IαI and PαI in the sample.
4 more elements
Dependencies are inferred from the claim text.